secwatch.observer — SEC 8-K summary
======================================

Issuer:     Novo Integrated Sciences, Inc. (—)
CIK:        0001138978
Form:       8-K
Filed at:   2023-01-30T23:59:59+00:00
Accession:  0001493152-23-002939
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq warns Novo of delisting for unfiled 10-K and 10-Q; issues 39.4M shares on note conversions
--------------------------------------------------------------------------------

- New Nasdaq notice (Jan 25, 2023) adds failure to file Form 10-Q to prior 10-K delinquency.
- Company must submit plan by Feb 13, 2023; Nasdaq may grant exception until June 12, 2023.
- Issued 39,397,034 shares on conversion of convertible notes Jan 26-30; outstanding now 128,258,227.
- After conversions, principal balances: Hudson Bay Master Fund $300,000; CVI Investments $6,110.75.
- Company intends to file 10-K and 10-Q promptly to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1138978/000149315223002939/0001493152-23-002939-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1138978/000149315223002939/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-002939

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer